Skip to main content
. 2003 Apr 22;2003(2):CD004258. doi: 10.1002/14651858.CD004258

Comparison 13. INTRA‐ARTICULAR STEROID INJECTION VERSUS PHYSIOTHERAPY (MOBILISATION, EXERCISE AND ELECTROTHERAPY).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Improvement in severity of main complaint at 3 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Improvement in severity of main complaint at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Improvement in severity of main complaint at 13 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Improvement in severity of main complaint at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Improvement in severity of main complaint at 52 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Pain at 2‐3 weeks (100cm VAS) 2 133 Mean Difference (IV, Fixed, 95% CI) ‐12.18 [‐18.61, ‐5.75]
6.1 Adhesive capsulitis 1 109 Mean Difference (IV, Fixed, 95% CI) ‐10.00 [‐18.67, ‐5.33]
6.2 Rotator cuff disease 1 24 Mean Difference (IV, Fixed, 95% CI) ‐14.60 [‐38.91, 9.71]
7 Improvement in severity of day pain at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Improvement in severity of day pain at 13 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Improvement in severity of day pain at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Improvement in severity of day pain at 52 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Improvement in severity of night pain at 3 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Improvement in severity of night pain at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
12.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Improvement in severity of night pain at 13 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
13.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Improvement in severity of night pain at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
14.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Improvement in severity of night pain at 52 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
15.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Improvement in severity as rated by observer at 3 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
16.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Improvement in severity as rated by observer at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
17.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Improvement in severity as rated by observer at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
18.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Improvement in rating of shoulder disability at 3 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
19.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Improvement in rating of shoulder disability at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
20.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Improvement in rating of shoulder disability at 13 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
21.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 Improvement in rating of shoulder disability at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
22.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Improvement in rating of shoulder disability at 52 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
23.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 Range of abduction (degrees) at 2‐3 weeks 2 133 Mean Difference (IV, Fixed, 95% CI) 5.0 [0.36, 9.64]
24.1 Adhesive capsulitis 1 109 Mean Difference (IV, Fixed, 95% CI) 5.0 [0.31, 9.69]
24.2 Rotator cuff disease 1 24 Mean Difference (IV, Fixed, 95% CI) 5.0 [‐24.93, 34.93]
25 Improvement in degree of restriction of ROM of abduction at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
25.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
26 Improvement in degree of restriction of ROM of abduction at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
26.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
27 Improvement in degree of restriction of ROM of ER at 3 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
27.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
28 Improvement in degree of restriction of ROM of ER at 7 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
28.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
29 Improvement in degree of restriction of ROM of ER at 26 weeks 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
29.1 Adhesive capsulitis 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
30 Number needing additional treatment at 7 weeks 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
30.1 Adhesive capsulitis 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
31 Frequency of adverse reactions 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
31.1 pain after treatment > 2 days 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
31.2 facial flushing 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
31.3 irregular menstrual bleeding 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
31.4 fever 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
31.5 skin irritation 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
31.6 overall 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
32 Short term treatment success 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
32.1 Rotator cuff disease 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]